These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 39000217)

  • 1. Current View on PPAR-α and Its Relation to Neurosteroids in Alzheimer's Disease and Other Neuropsychiatric Disorders: Promising Targets in a Therapeutic Strategy.
    Żulińska S; Strosznajder AK; Strosznajder JB
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer's Disease and Other Neurodegenerative Disorders.
    Wójtowicz S; Strosznajder AK; Jeżyna M; Strosznajder JB
    Neurochem Res; 2020 May; 45(5):972-988. PubMed ID: 32170673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Strategy of Targeting Peroxisome Proliferator-Activated Receptor (PPAR) in the Treatment of Neuropsychiatric Disorders.
    Matrisciano F; Pinna G
    Adv Exp Med Biol; 2023; 1411():513-535. PubMed ID: 36949324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets.
    Dey AD; Mannan A; Dhiman S; Singh TG
    Psychopharmacology (Berl); 2024 Aug; 241(8):1491-1516. PubMed ID: 38801530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration.
    Durai P; Beeraka NM; Ramachandrappa HVP; Krishnan P; Gudur P; Raghavendra NM; Ravanappa PKB
    Curr Neuropharmacol; 2022; 20(5):893-915. PubMed ID: 34751120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's Disease, a Lipid Story: Involvement of Peroxisome Proliferator-Activated Receptor α.
    Sáez-Orellana F; Octave JN; Pierrot N
    Cells; 2020 May; 9(5):. PubMed ID: 32422896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the Role of Peroxisome Proliferator-activated Receptor α and Phosphodiesterase Type 5 Targets in Alzheimer's Disease.
    Sose PM; Kale PP; Doshi GM
    CNS Neurol Disord Drug Targets; 2024; 23(8):956-970. PubMed ID: 37670711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?
    Tufano M; Pinna G
    Molecules; 2020 Feb; 25(5):. PubMed ID: 32120979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Liver X Receptors and Peroxisome Proliferator-Activated Receptors by Lipid Extracts of Brown Seaweeds: A Potential Application in Alzheimer's Disease?
    Martens N; Zhan N; Voortman G; Leijten FPJ; van Rheenen C; van Leerdam S; Geng X; Huybrechts M; Liu H; Jonker JW; Kuipers F; Lütjohann D; Vanmierlo T; Mulder MT
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurosteroids: A potential target for neuropsychiatric disorders.
    Wang M; Hu S; Fu X; Zhou H; Yang S; Yang C
    J Steroid Biochem Mol Biol; 2024 May; 239():106485. PubMed ID: 38369032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting PPARalpha in Alzheimer's Disease.
    D'Orio B; Fracassi A; Ceru MP; Moreno S
    Curr Alzheimer Res; 2018 Feb; 15(4):345-354. PubMed ID: 28474570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptors (PPARs) as therapeutic target in neurodegenerative disorders.
    Agarwal S; Yadav A; Chaturvedi RK
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1166-1177. PubMed ID: 27514452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of synthetic ligand of PPARα in regulation of transcription of genes related to mitochondria biogenesis and dynamic in an animal model of Alzheimer's disease.
    Żulińska S; Strosznajder AK; Strosznajder JB
    Folia Neuropathol; 2023; 61(2):138-143. PubMed ID: 37587888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy.
    Strosznajder AK; Wójtowicz S; Jeżyna MJ; Sun GY; Strosznajder JB
    Neuromolecular Med; 2021 Mar; 23(1):86-98. PubMed ID: 33210212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease.
    Kumar M; Ashok SA; Datusalia AK; Khatik GL
    Med Chem; 2024 May; ():. PubMed ID: 38726789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPARα) and its lipid ligands.
    Fidaleo M; Fanelli F; Ceru MP; Moreno S
    Curr Med Chem; 2014; 21(24):2803-21. PubMed ID: 24606520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor (PPAR) γ and PPARα agonists modulate mitochondrial fusion-fission dynamics: relevance to reactive oxygen species (ROS)-related neurodegenerative disorders?
    Zolezzi JM; Silva-Alvarez C; Ordenes D; Godoy JA; Carvajal FJ; Santos MJ; Inestrosa NC
    PLoS One; 2013; 8(5):e64019. PubMed ID: 23675519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects.
    Tong B; Ba Y; Li Z; Yang C; Su K; Qi H; Zhang D; Liu X; Wu Y; Chen Y; Ling J; Zhang J; Yin X; Yu P
    Neurobiol Dis; 2024 Jun; 196():106505. PubMed ID: 38642715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.